Publications
1988-1989 | 1990-1994 | 1995-1999 | 2000-2004 | 2005-2009 | 2010-2013 | 2017 | 2021 | 2022 | 2023
Baker, P., Cepeda, J., Schluth, C., Astemborski, J., Feder, K., Rudolph, J., Sun, J., Kirk, G., Mehta, S. & Genberg, B. (2023). Time-to-completion of COVID-19 vaccination primary series varies by HIV viral load status among people who inject drugs in Baltimore, Maryland. Preventive Medicine Reports. 36. 102448. 10.1016/j.pmedr.2023.102448.
Coyle, C., Desjardins, M., Curriero, F., Rudolph, J., & Astemborski, J., & Falade-Nwulia, O., Kirk, G., Thomas, D., Mehta, S., & Genberg, B. (2023). Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD. Journal of viral hepatitis. 30. 10.1111/jvh.13864.
Feder, K., Patel, E., & Buresh, M., Kirk, G., Mehta, S., & Genberg, B. (2023). Trends in Self-Reported Non-Fatal Overdose and Patterns of Substance Use Before and During the COVID-19 Pandemic in a Prospective Cohort of Adults who Have Injected Drugs Baltimore, Maryland, 2014-2022. Drug and Alcohol Dependence. 251. 110954. 10.1016/j.drugalcdep.2023.110954.
Kim, J., Newcomb, C., Carbonari, D., Torgersen, J., Althoff, K., Kitahata, M., Klein, M., Moore, R., Reddy, R., Silverberg, M., Mayor, A., Horberg, M., Cachay, E., Lim, J., Gill, M., Chew, K., Sterling, T., Hull, M., Seaberg, E, & Lo Re, V. (2023). Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016. PloS one. 18. e0290889. 10.1371/journal.pone.0290889.
Koehler, K., Wilks, M., Green, T., Rule, A. M., Zamora, M. L., & Buehler, C., Datta, A., Gentner, D. R., Putcha, N., Hansel, N. N., Kirk, G., Raju, S. & McCormack, M. (2023). Evaluation of calibration approaches for indoor deployments of PurpleAir monitors. Atmospheric Environment. 310. 119944. 10.1016/j.atmosenv.2023.119944.
Luken, A., Rabinowitz, J., Wells, J., Sosnowski, D., Strickland, J., Thrul, J., Kirk, G. & Maher, B. (2023). Designing and Validating a Novel Method for Assessing Delay Discounting Associated with Health Behaviors: Findings from an Ecological Momentary Assessment Study (Preprint). 10.2196/preprints.48954.
McLaren, P., Porreca, I., Iaconis, G., Mok, H., Mukhopadhyay, S., Karakoç, E., Cristinelli, S., Pomilla, C., Bartha, I.,Thorball, C., & Tough, R., Angelino, P., Kiar, C., Carstensen, T., Fatumo, S., Porter, T., Jarvis, I., Skarnes, W., & Bassett, A., & Fellay, J. (2023). Africa-specific human genetic variation near CHD1L associates with HIV-1 load. Nature. 620. 1-6. 10.1038/s41586-023-06370-4.
Nsibirwa, S., Aizire, J., Mugerwa, J., Thomas, D., Ocama, P., & Kirk, G. (2023). The impact of HIV infection on clinical presentation and mortality among persons with hepatocellular carcinoma in Kampala, Uganda. BMC Infectious Diseases. 23. 10.1186/s12879-023-08164-5.
Patel, E., Astemborski, J., Feder, K., Rudolph, J., Winiker, A., Sosnowski, D., Kirk, G. Mehta, S., & Genberg, B. (2023). Temporal association of pre-pandemic perceived social support with psychological resilience and mental well-being during the COVID-19 pandemic among people with a history of injection drug use. Drug and Alcohol Dependence. 244. 109802. 10.1016/j.drugalcdep.2023.109802.
Rani, P., Mehta, S., Kathapalia, J., Tyagi, R. Impact of Social Media on Physical and Psychological Health of the Students. Indian Journal of Health and Wellbeing. Vol 14, No 1 (2023). Pagination: 48-52.
Wekesa, C., & Parkes-Ratanshi, R., Kirk, G & Ocama, P. (2023). Liver Injury Patterns and Hepatic Toxicity among People Living with and without HIV and Attending Care in Urban Uganda. International Journal of Hepatology. 2023. 1-7. 10.1155/2023/6717854.
Althoff, K. & Stewart, C., Humes, E., & Gerace, L., Boyd, C., Gebo, K., & Justice, A., Hyle, E., Coburn, S., Lang, R., Silverberg, M., Horberg, M., & Lima, V., Gill, M., Karris, M., Rebeiro, P., Thorne, J., Rich, A., Crane, H., & Kasaie, P. (2022). The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030. 10.1101/2022.11.04.22281891.
Baker, P., Cepeda, J., Schluth, C., Astemborski, J., Feder, K., Rudolph, J., Sun, J., Kirk, G., Mehta, S., & Genberg, B. (2023). Time-to-Completion of Covid-19 Vaccination Primary Series Varies by HIV Viral Load Status Among People Who Inject Drugs in Baltimore, Maryland. 10.2139/ssrn.4423541.
Cepeda, J. A.,et.al (2022). Impact of Hepatitis C Treatment Uptake on Cirrhosis and Mortality in Persons Who Inject Drugs : A Longitudinal, Community-Based Cohort Study. Annals of internal medicine, 175(8), August 2022.
Cepeda J.A. (COVID-19 Vaccine Hesitancy and Vaccination Status in a Community-Based Cohort of People Who Inject Drugs in Baltimore, Maryland, March–June 2021.Public Health Rep,137(5), Sep-Oct 2022.
Chebrolu, P., Mcfall, A., Brown, T & Srikrishnan, A.K., & Kumar, M., Iqbal, H. Mathad, J. Lucas, G., & Solomon, & S. Mehta, S. (2023). 1274-P: High Prevalence of Type 2 Diabetes without Traditional Risk Factors among Men Who Inject Drugs in Chennai, India. Diabetes. 72. 10.2337/db23-1274-P.
Feder, K., Sun, J., Genberg, B., Musci, R., Mojtabai, R., Sosnowski, D. McCall, L., Astemborski, J., Hollander, E., Loving, L. Kirk, G. & Mehta, S. (2022). Association of Childhood Adversity with Heroin and Cocaine Use Across the Life Course of People Who Inject Drugs. SSRN Electronic Journal. 10.2139/ssrn.4103106.
Feder K.A., et. al. (2022). Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada. Drug and Alcohol Dependence,241, December 2022.
Feder K.A., et.al. (2022). Mortality by cause of death during year 1 of the COVID-19 pandemic in a cohort of older adults from Baltimore Maryland who have injected drugs. The International Journal on Drug Policy, 109, August 2022. â¶Ä‚â¶Ä‚â¶Ä‚â¶Ä‚â¶Ä‚ â¶Ä‚â¶Ä‚â¶Ä‚â¶Ä‚â¶Ä‚  
Gorbach P.M. Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV. Drug and Alcohol Dependence. September 2022.
Heidari, O., et. al. (2022). Multimorbidity classes indicate differential patterns of health care engagement among people who inject drugs. Journal of substance abuse treatment, 142, November 2022.
Lesko, C. R. (2022). COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug and Alcohol Dependence, 241, December 2022.
Moallef S. (2022). Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada. Drug and Alcohol Dependence, 241, December 2022.
Raju, Sarath & Gearhart, Andrew & Drummond, M & Brown, Nicole & Ramamurthi, Hema & Kirk, Gregory & Brown, Robert & Mccormack, Meredith. (2022). HIV-associated COPD Is Characterized by Increased Small Airways Dysfunction on CT. Annals of the American Thoracic Society. 20. 10.1513/AnnalsATS.202203-203RL.
Shu, C., et. al. (2022). Epigenome-wide association analyses of active injection drug use. Drug and alcohol dependence, 235,June 2022.
Sosnowski, D. W., et. al. (2022). Adverse childhood experiences and comorbidity in a cohort of people who have injected drugs. BMC public health, 22(1), May 2022.   
Valencia, A., et. al. (2022). Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1. American journal of human genetics, 109(2), February 2022.
Wang, R., Rothman, R., Mohareb, A., Laeyendecker, O., Cloherty, G., Quinn, T., Hsieh, Y., Anderson, M., Solomon, S., Fernandez, R., Dashler, G., Mehta, R., Stec, M., Kickler, T., Kelen, G., Mehta, S., Beck, E., Saraf, S., Baker, O., & Hurley, J. (2022). High Burden of Undiagnosed Hepatitis B and Liver Disease in an Urban Emergency Department – Baltimore, 2020. Clinical Gastroenterology and Hepatology. 10.1016/j.cgh.2022.10.033.
Baum M. K. (2021). HIV, Psychological Resilience, and Substance Misuse During the COVID-19 Pandemic: A Multi-Cohort Study. Drug and Alcohol Dependence, 231, February 2022.
Cepeda JA, Thomas DL, Astemborski J, Sulkowski MS, Kirk GD, Mehta SH. . Clin Infect Dis, 65(2):235-243. PMID: 28329108.
Shiels MS, Kirk GD, Drummond MB, Dhillon D, Hanash SM, Taguchi A, Engels EA. HIV infection and circulating levels of pro-surfactant protein b and surfactant protein d. J Infect Dis (In press).
Dubrow R, Qin L, Lin H, Hernandez-Ramirez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, D’Souza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. . JAIDS, 2017; 75(4):382-390. PMCID: PMC5490794.
Quinn J, Astemborski J, Mehta SH, Kirk GD, Thomas DL, Balagopal A. . Pathog Immun, 2017; 2(1):50-59. PMCID: PMC5425162.
Veenhuis RT, Astemborski J, Chattergoon MA, Greenwood P, Jarosinski M, Moore RD, Mehta SH, Cox AL. . Clin Infect Dis, 2017; 64(5):589-596. PMID: 27927859.
Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH, Busch M, Murphy EL, Villacres MC, Peters MG, French AL, Golub E, Eron J, Lahiri CD, Shrestha S, Gustafson D, Young M, Anastos K, Aouizerat B, Kim AY, Lauer G, Thomas DL, Duggal P. . Genes Immun, 2017; 18(2):82-87. PMCID: PMC5408324.
Ramsuran V, Hernandez-Sanchez PG, O’hUigin C, Sharma G, Spence N, Augusto DG, Gao X, Garcia-Sepulveda CA, Kaur G, Mehra NK, Carrington M. . J Immunol, 2017; 198(6):2320-2329. PMID: 8148735; PMCID: PMC5340644.
Westergaard RP, Genz A, Panico K, Surkan PJ, Keruly J, Hutton HE, Chang LW, Kirk GD. . Addict Sci Clin Pract, 2017; 12 (1):11. PMCID: PMC5405459.
Piggott DA, Muzaale AD, Varadhan R, Mehta SH, Westergaard RP, Brown TT, Patel KV, Walston JD, Leng SX, Kirk GD. . J Gerontol A Biol Sci Med Sci, 2017; 72(3):389-394. PMID: 27516622.
Drummond MB, Lambert AA, Hussien AF, Lin CT, Merlo CA, Wise RA, Kirk GD, Brown RH. . Acad Radiol, 2017; 24(2):137-145. PMCID: PMC5237394.
2016
Popescu I, Drummond MB, Gama L, Lambert A, Hoji A, Coon T, Merlo CA, Wise RA, Keruly J, Clements JE, Kirk GD, McDyer JF. . J Infect Dis, 2016; 214(10):1520-1530. PMCID: PMC5091376.
Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R. . Clin Infect Dis, 2016; 63(9):1160-1167. PMCID: PMC5064164.
Walker-Sperling V, Merlo C, Buckheit R, Lambert A, Tarwater P, Kirk G, Drummond B, Blankson J. . AIDS Res Hum Retroviruses, 2016; 32:1097-1099. PMCID: PMC5067835.
Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, Rachlis A, Thorne JE, Napravnik S, Henry K, Mayor A, Gebo K, Gange SJ, Moore RD, Brooks JT. I. J Infect Dis, 2016; 214 (6):862-872. PMCID: PMC4996145.
Pavasini R, Guralnik J, Brown JC, di Bari M, Cesari M, Landi F, Vaes B, Legrand D, Verghese J, Wang C, Stenholm S, Ferrucci L, Lai JC, Bartes AA, Espaulella J, Ferrer M, Lim JY, Ensrud KE, Cawthon P, Turusheva A, Frolova E, Rolland Y, Lauwers V, Corsonello A, Kirk GD, Ferrari R, Volpato S, Campo G. . BMC Med, 2016; 14 (1):215. PMCID: PMC5178082.
Koethe JR, Jenkins CA, Lau B, Shepherd BE, Wester W, Rebeiro PF, Silverberg MJ, Thorne JE, Gill J, Mayor AM, Willig A, Bosch R, Horberg MA, Justice AC, Sterling TR, Moore RD, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). . JAIDS, 2016; 73(2): 197-204. PMCID: PMC5023455.
Brune KA, Ferreira F, Mandke P, Chau E, Aggarwal NR, D'Alessio FR, Lambert AA, Kirk G, Blankson J, Drummond MB, Tsibris AM, Sidhaye VK. . PLoS One, 2016; 11 (3):e0149679. PMCID: PMC4773117.
Cesar C, Koethe JR, Giganti MJ, Rebeiro P, Althoff KN, Napravnik S, Mayor A, Grinsztejn B, Wolff M, Padgett D, Sierra-Madero J, Gotuzzo E, Sterling TR, Willing J, Levison J, Kitahata M, Rodriguez-Barradas MC, Moore RD, McGowan C, Shepherd BE, Cahn P, Caribbean, Central and South America Network for HIV epidemiology (CCASAnet) and North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). . J Int AIDS Soc, 2016; 19(1):20684. PMCID: PMC4800379.
Lam Y, Westergaard R, Kirk G, Ahmadi A, Genz A, Keruly J, Hutton H, Surkan PJ. . PLoS One, 2016; 11 (7):e0158759. PMCID: PMC4948838.
Pettit AC, Mendes A, Jenkins C, Napravnik S, Freeman A, Shepherd BE, Dowdy D, Gill J, Rachlis A, Moore R, Sterling TR, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) investigators of International epidemiologic Databases to Evaluate AIDS (IeDEA). . JAIDS, 2016; 72(5): 572-578. PMCID: PMC4942351.
Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AM, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, Blashill AJ, Willig A, Wester CW, Silverberg MJ, Gill J, Thorne JE, Klein M, Eron JJ, Kitahata MM, Sterling TR, Moore RD, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). . PLOS One, 2016; 11(1):e0146119. PMCID: PMC4708981.
Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O. . J Infect Dis, 2016; 214(3):344-352. PMCID: PMC4936640.
An P, Penugonda S, Thorball CW, Bartha I, Goedert JJ, Donfield S, Buchbinder S, Binns-Roemer E, Kirk GD, Zhang W, Fellay J, Yu XF, Winkler CA. . PLoS Genet, 2016; 12 (3):e1005921. PMCID: PMC4778847.
Linas BS, Genz A, Westergaard RP, Chang LW, Bollinger RC, Latkin C, Kirk GD. . JMIR MHealth UHealth, 2016; 4(1):e27. PMCID: PMC4812047.
Lambert AA, Drummond MB, Kisalu A, Moxley J, Keruly J, Moore RD, Wise RA, Kirk GD. . COPD, 2016; 13(6):767-772. PMCID: PMC5073036.
Vergara C, Thio CL, Thomas D, Duggal P. . Hepatology, 2016; 63(3):1061-1062. PMCID: PMC4689676.
Rachlis B, Karwa R, Chema C, Pastakia S, Olsson S, Wools-Kaloustian K, Jakait B, Maina M, Yotebieng M, Kumarasamy N, Freeman A, de Rekeneire N, Duda SN, Davies M, Braitstein P. . Drug Saf, 2016; 39(10):959-976. PMCID: PMC5018020.
Mehta SH, Thomas DL. . J Hepatol, 2016; 65(1):5-6. PMCID: PMC4912864.
Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O. . AIDS Res Hum Retroviruses, 2016; 32 (8):756-762. PMCID: PMC4971410.
Leader JK, Crothers K, Huang L, King MA, Morris A, Thompson BW, Flores SC, Drummond MB, Rom WN, Diaz PT. . J Acquir Immune Defic Syndr, 2016; 71(4):420-427. PMCID: PMC4770858.
Drummond MB, Kunisaki KM, Huang L. . Semin Respir Crit Care Med, 2016; 37(2):277-288. PMCID: PMC4809361.
2015
da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, Sangrajrang S, Khuhaprema T, Mendy M, Lesi OA, Chang HK, Oh JK, Lee DH, Shin HR, Kirk GD, Merle P, Beretta L, Hainaut P. . Int J Cancer, 2015; 136 (1):172-181. PMID: PMC24803312
Linas BS, Latkin C, Westergaard RP, Chang LW, Bollinger RC, Genz A, Kirk GD. Addiction, 2015; 110(2):315-325. PMID: PMC4447335.
Genz A, Kirk GD, Piggott DA, Mehta SH, Linas BS, Westergaard RP. JMIR MHealth UHealth, 2015; 3(2):e70. PMID: PMC4526964
Lambert AA, Kirk GD, Astemborski J, Mehta SH, Wise RA, Drummond MB. . J Acquir Immune Defic Syndr, 2015; 69(1):68-74. PMID: PMC4422097
Genberg BL, Astemborski J, Vlahov D, Kirk GD, Mehta SH. Addiction, 2015; 110(7):1152-1159.PMID: PMC4478154
O’Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm M, Morgan TR, Pearce CL, Strickler H, Thomas DL, Prokunina-Olsson L. . J Hepatol, 2015. PMID:PMC26186989
Bailey JR, Dowd KA, Snider AE, Osburn WO, Mehta SH, Kirk GD, Thomas DL, Ray SC. J Infect Dis, 2015; 212(6):914-923. PMID: PMC4548462
Yang C†, Linas B, Kirk G, Bollinger R, Chang L, Chander G, Siconolfi D, Braxton S, Rudolph A, Latkin C. JMIR MHealth UHealth, 2015; 3(2):e67.
Linas BS, Latkin C, Genz A, Westergaard RP, Chang LW, Bollinger RC, Kirk GD. . Drug Alcohol Depend, 2015; 151:250-257. PMID: PMC4447533
Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane H, Eron J, Gill MJ, Horberg MA, Justice AC, Klein M, Mayor AM, Moore RD, Palella FJ, Parikh CR, Silverberg MJ, Golub ET, Jacobson LP, Napravnik S, Lucas GM. Clin Infect Dis, 2015; 60(6):941-949. PMID: PMC4357817
Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R. Ann Intern Med, 2015; 163 (7):507-518. PMID: PMC4447533
McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, De Luca A, Goedert JJ, Gurdasani D, Haas DW, Herbeck JT, Johnson EO, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, Poli G, Sandhu MS, Schuitemaker H, Shea PR, Theodorou I, Walker BD, Weintrob AC, Winkler CA, Wolinsky SM, Raychaudhuri S, Goldstein DB, Telenti A, de Bakker PI, Zagury JF, Fellay J. . Proc Natl Acad Sci U S A, 2015; 112 (47):14658-14663.
Leng SX, Dandorf S, Li H, Carlson J, Hui J, Mehta SH, Piggott D, Islam S, Manwani B, Kirk GD. . AIDS Res Hum Retroviruses, 2015; 31 (12):1257-1264.
Smith DK, Pan Y, Rose CE, Pals SL, Mehta SH, Kirk, GD, Herbst JH. . J Addict Med 2015; 9(3):226-32. doi: 10.1097/ADM.0000000000000123. PMCID: PMC4449303
Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D. J Acquir Immune Defic Syndr. 2015 May 1;69(1):18-28. doi: 10.1097/QAI.0000000000000551
Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP. AIDS Behav. 2015 Apr;19(4):601-11. doi: 10.1007/s10461-014-0927-4. PubMed PMID: 25342151; PubMed Central PMCID: PMC4393774.
Drummond MB, Huang L, Diaz PT,Kirk GD, Kleerup EC, Morris A, Rom W, Weiden MD, Zhao E, Thompson B, Crothers K. F AIDS, 2015; 29 (13):1691-1700.
Robbins HA, Fennell CE, Gillison M, Xiao W, Guo Y, Wentz A, Kirk GD, Mehta SH, D'Souza G. PLoS One, 2015; 10 (11):e0143698.
Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O. . J Infect Dis, 2015.
Piggott DA†, Varadhan R, Mehta SH, Brown TT, Li H, Walston JD, Leng SX, Kirk GD. J Gerontol A Biol Sci Med Sci, 2015; 70 (12):1542-1547.
2014
Etemad B, Gonzalez OA, White L, Laeyendecker O, Kirk GD, Mehta SH, Sagar M. . Retroviorology 2014;11(1): 106. PMCID:PMC4253609
Duggal P, Wojcik G, Thio C, Latanich R, Goedert J, Mehta SH, Kirk G, Peters M, Cox A, Kim A, Chung R, Thomas D. . Genes Immun 2014; 15(4):241-6. PMCID: PMC4308959
Greene M, Covinsky K, Astemborski J, Piggott DA, Brown T, Leng S, Galai N, Mehta SH, Guralnik J, Patel KV, Kirk GD. AIDS. 2014 Nov 28;28(18):2711-9. doi: 10.1097/QAD.0000000000000507. PubMed PMID: 25493597; PubMed Central PMCID: PMC4380225
Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. HIV diversity as a biomarker for HIV incidence estimation: Including a high-resolution melting diversity assay in a multiassay algorithm. J Clin Microbiol, 2014; 52(1): 115-21.
Longosz AF, Mehta SH, Kirk GD, Margolick JD, Brown J, Quinn TC, Eshleman SH, Laeyendecker O. Incorrect identification in recent HIV infection in adults in the United States using a limited-antigen avidity assay. AIDS, 2014; 28(8): 1227-32.
Linton SL†, Jennings JJ, Latkin C, Kirk GD, Mehta SH. The association between neighborhood residential rehabilitation and injection drug use in Baltimore, Maryland, 2000-2011. Health & Place, 2014; 28C:142-149.
Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Kobin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS ONE, 2014; 9(6):e101043.
Wojcik GL, Thio CL, Kao WH, Latanich R, Goedert JJ, Mehta SH, Kirk GD, Peters MG, Cox AL, Kim AY, Chung RT, Thomas DL, Duggal P. Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent. Genes Immun, 2014; 15(4):241-6.
Hulbert A, Hooker CM, Keruly JC, Brown T, Horton K, Fishman E, Rodgers K, Lee B, Sam C, Tsai S, Weihe E, Pridham G, Drummond B, Merlo C, Geronimo M, Porter M, Cox S, Li D, Harline M, Teran M, Wrangle J, Mudge B, Taylor G, Kirk GD, Herman JG, Moore RD, Brown RH, Brock MV. Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers. J Thorac Oncol, 2014; 9(6):752-9.
An P, Goedert JJ, Donfield S, Buchbinder S, Kirk GD, Detels R, Winkler CA. Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisition. J Infect Dis, 2014; [Epub ahead of print]
Lambert AA†, Drummond MB, Mehta SH, Brown TT, Lucas GM, Kirk GD, Estrella MM. Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users. PLoS One, 2014; 9(4):e95802.
, , , , , , , , , , , , , , , , , , ; . Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis, 2014; 58(8):1185-9.
Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH, Duggal P, Hussain S, Martinson J, Weintrob A, Kirk GD, Fellay J, Buchbinder SP, Goedert JJ, Deeks SG, Pereyra F, Trowsdale J, Lichterfeld M, Telenti A, Walker BD, Allen RL, Carrington M, Yu XG. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. PLoS Genet, 2014; 10(3):e1004196.
Drummond MB†, Kirk GD. HIV-associated lung disease: Recent insights and implications for the clinician. Lancet Respir Med, 2014.
Lambert AA†, Kirk GD, Astemborski J, Neptune E, Mehta SH, Wise R, Drummond MB. A cross-sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort. PLoS ONE, 2014; 9(4): e95099.
Popescu I, Drummond MB, Gama L, Merlo CA, Astemborski J, Brown RH, Wise RA, Clements JE, Kirk GD, McDyer JF. Activation-induced cell death drives profound lung CD4+ T cell depletion in HIV-associated chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2014. [Epub ahead of print]
Drummond MB†, Astemborski J, Lambert AA, Goldberg S, Stitzer ML, Merlo CA, Rand CS, Wise RA, Kirk GD. A randomized pilot study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users. BMC Public Health, 2014; 28(14):761
Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk GD, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore R, Gange SJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One, 2013; 8(12):e8135.
Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. . Am J Epidemiol 2013;177:264-72.
Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL. Ann Intern Med 2013;158:235-45. PMCID: PMC3638215.
Kirk GD, Mehta SH, Astemborski J, Galai N, Washington J, Higgins Y, Balagopal A, Thomas DL. Ann Intern Med 2013;158:658-66.
Piggott DA, Muzaale AD, Mehta SH, Brown TT, Leng SX, Kirk GD. .Plos One 2013;8:e54910. PMCID: PMC3561408.
Howe CJ, Cole SR, Mehta SH, Kirk GD. . Epidemiology 2012; 23(4):574-82. PMCID: PMC3367098.
Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. Nat Genet 2013; 45(2):164-71. PMCID: PMC3793390.
Linton SL, Celentano DD, Kirk GD, Mehta SH. . Drug Alcohol Depend 2013; 132(3): 457-65.
Linton SL, Kennedy CE, Latkin CA, Celentano DD, Kirk GD, Mehta SH. "Everything that looks good ain't good!": . Int J Drug Policy 2013; 24(6): 605-13.
Genberg BL, Gillespie M, Schuster CR, Johanson CE, Astemborski J, Kirk GD, Vlahov D, Mehta SH. . Addict Behav 2013; 38 (12): 2868-73. PMCID: PMC3805723.
2012
Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne JE, Crane HM, Mugavero MJ, Napravnik S, Kirk GD, Jacobson LP, Brooks JT; North American AIDS Cohort Collaboration on Research and Design. . Ann Intern Med 2012;157:325-35. PMCID:PMC3534765.
Chatziandreou N, Arauz AB, Freitas I, Nyein PH, Fenton G, Mehta SH, Kirk GD, Sagar M. AIDS Res Hum Retroviruses (in press).
Claassen CW, Diener-West M, Mehta SH, Thomas DL, Kirk GD. . Clin Infect Dis 2012;54:1806-13.
Deng Z, Gao X, Kirk GD, Wolinsky S, Carrington M. . Hum Immunol 2012;73:715-9. PMCID: PMC3377779.
Drummond MB, Kirk GD, Astemborksi J, Marshall MM, Mehta SH, McDyer JF, Brown RH, Wise RA and Merlo CA. Thorax 2012;67:309-14.
Estrella M, Kirk GD, Mehta SH, Brown TT, Fine DM, Atta MG, Lucas GM. AIDS 2012;26:295-302.
Fu T, Westergaard RP, Lau B, Celentano DD, Vlahov D, Mehta SH, Kirk GD. . AIDS 2012 Nov; 26(18): 2383-91.
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ; North American AIDS Cohort Collaboration on Research and Design. . Clin Infect Dis 2013;56(8):1174-82.
Howe CJ, Cole SR, Mehta SH, Kirk GD. . Epidemiology 2012;23:574-582. PMCID: PMC3367098.
Justice A, Modur S, Tate J, Althoff K, Jacobson L, Gebo K, Rourke S, Rachlis A, Moore R, Kirk GD, Bosch R, Rodriguez B, Hogg R, Goedert J, Gill M, Deeks S, Sterling T, Anastos K, Gange S. . J Acquir Immune Defic Syndr (in press).
Kornek M, Lynch M, Mehta SH, Lai M, Exley M, Afdhal NH, Schuppan D. Gastroenterology 2012;143:448-58.
Mehta SH, Kirk GD, Astemborski J, Sulkowski MS, Afdhal N, Thomas DL. Antiviral therapy 2012;17:813-21.
Mehta SH, Sudarshi D, Srikrishnan AK, Celentano DD, Vasudevan CK, Anand S, Kumar MS, Latkin C, Solomon S, Solomon SS. Addiction 2012:107:349-58. PMCID: PMC3222716.
Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen, KD, Astemborski J,Mehta, SH, Ray SC, Thomas, DL, Balagopal A. Hepatology 2012;56:544-54. PMCID: PMC3388175.
Thomas R, Thio CL, Apps R, Qi Y, Gao X, Marti D, Stein J, Soderberg K, Moody M, Goedert J, Kirk GD, Hoots W, Wolinsky S, Carrington M. . J Virol 2012. Jun; 86(12):6979-85. PMCID:PMC3393572
Westergaard RP, Ambrose BL, Mehta SH, Kirk GD. . J Int AIDS Soc 2012;15:10. PMCID: PMC3306203.
2011
An P, Li R, Wang JM, Yoshimura T, Takahashi M, Samudralal R, O'Brien SJ, Phair J, Goedert JJ, Kirk GD, Troyer JL, Sezgin E, Buchbinder SP, Donfield S, Nelson GW, Winkler CA. PLoS Genetics 2011;7:e1002328. PMCID: PMC3203199.
Bachetti P, Boylan R, Astemborski J, Shen H, Mehta SH, Thomas DL, Terrault NA, Monto A. PLOS one 2011;6:e20104. PMCID: PMC3103523.
Crothers K, Thompson BW, Burkhardt K, Morris A, Flores SC, Diaz PT, Chaisson RE, Kirk GD, Rom WN, Huang L. Proc Am Thoracic Soc 2011;8:275-81. PMCID: PMC3132785.
Degenhardt L, Singleton S, McLaren J, Kerr T, Mehta SH, Kirk GD, Hall W. Drug Alcohol Depend 2011;113:88-95.
Drummond MB, Kirk GD, Astemborski J, McCormack MC, Marshall MM, Mehta SH, Wise RA, Merlo CA. Int J Chron Obstruct Pulmon Dis 2011;6:89-95. PMCID: PMC3048084.
Genberg BL, Gange SJ, Go VF, Celentano DD, Kirk GD, Latkin CA, Mehta SH. Addiction 2011;106:1966-74. PMCID: PMC3189272.
Genberg BL, Gange SJ, Go VF, Celentano DD, Kirk GD, Mehta SH. Am J Epidemiol 2011;173:829-36. PMCID: PMC3070496.
Hsieh J-J, Ding AA, Wang W. Biometrics 2011;67:719-29.
Howe CJ, SR Cole, Ostrow D, Kirk GD, Mehta SH. AIDS 2011;25:221-8. PMCID: PMC3006640.
Kirk GD, Merlo CM. . Proc Am Thoracic Soc 2011;8:326-32. PMCID: PMC3132793.
Khosla N, Juon HS, Kirk GD, Astemborski J, Mehta SH. Addict Behavior 2011;36(12):1282-7. PMCID: PMC3179799.
Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, Hague JC, Mehta SH, Engels EA. Addict Behav 2011;36:6-17. PMCID: PMC2981673.
Mehta SH, Buckle G. Curr Opinion HIV/AIDS Res 2011;6(6):465-71.
Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL. J Infect Dis 2011;203:587-94. PMCID: PMC3072736.
Reuben J, Serio CS, Matens R, Sherman SG. Journal of Urban Health 2011;88:342-348. PMCID: PMC3079042.
Salgado M, Kirk GD, Cox A, Rutebemberwa A, Higgins Y, Astemborski J, Thomas DL, Thio CL, Sulkowski MS, Blankson JN. AIDS 2011;25:385-7. PMCID: PMC315898.
Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. Clin Infect Dis 2011;53: 1256-64. PMCID: PMC321458.
Seich al Basatena NK, MacNamara A, Vine AM, Thio CL, Astemborski J, Usuku K, Osame M, Kirk GD, Donfield SM, Goedert JJ, Bangham CRM, Carrington M, Khakoo SI, Asquith B. . PLoS Pathog 2011;7:e1002270. PMCID: PMC3192839.
Sherman SG, Reuben J, Chapman CS, Lilleston P. Drug and Alcohol Dependence 2011;114:249-252.
Sherman SG, Lilleston P, Reuben J. Soc Sci Med 2011;73:475-81. PMCID: PMC3154252.
Solomon SS, Srikrishnan AK. Celentano DD, Johnson SC, Vasudevan CK, Murugavel KG, Anand S, Kumar MS, Solomon S, Mehta SH. BMC Pub Health 2011;11:39. PMCID: PMC3031221.
Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, Johnson RC, Sezgin E, Kessing B, Malasky M, Hendrickson SL, Li G, Pontius J, Tang M, An P, Winkler CA, Limou S, Le Clerc S, Delaneau O, Zagury JF, Schuitemaker H, van Manen D, Bream JH, Gomperts ED, Buchbinder S, Goedert JJ, Kirk GD, O'Brien SJ. J Infect Dis 2011; 203:1491-502. PMCID: PMC3080910.
Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. J Infect Dis 2011;53:725-31. PMCID: PMC3202322.
Zeremski M, Dimova RB, Astemborski J, Thomas DL, Talal AH. J Infect Dis 2011;204:832-6. PMCID: PMC3156920.
2010
Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Calzavara LM, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Kushel M, Goedert JJ, McKaig RG, Van Rompaey SE, Zhang J, Moore RD. Clin Infect Dis 2010; 50:1512-20. PMCID: PMC2862849.
Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Thorne J, Rachlis A, Moore RD, Justice AC. AIDS Res Therapy 2010;7:45. PMCID: PMC3066223.
Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA; North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD). AIDS 2010;24:2469-79. PMCID: PMC3136814.
Chinn LW, Tang M, Kessing BD, Lautenberger JA, Troyer JL, Malasky MJ, McIntosh C, Kirk GD, Wolinsky SM, Buchbinder SP, Gomperts ED, Goedert JJ, O’Brien SJ. J Infect Dis 2010;202:1836-45. PMCID: PMC3107555.
Drummond MB, Kirk GD, Ricketts EP, McCormack MC, Hague JC, McDyer JF, Mehta SH, Engels EA, Wise RA, Merlo CM. BMC Pulm Med 2010;10:27. PMCID:PMC2876103.
Drummond MB, Kirk GD, McCormack MC, Marshall MM, Ricketts EP, Mehta SH, Wise RA, Merlo CM.
Qual Life Res 2010;19:1295-1302.
Genberg B, Gange S, Go V, Celentano D, Kirk GD, Mehta SH. Am J Epidemiol 2010;173:829-36. PMCID: PMC3070496.
Gravitt PE, Kirk GD. J Infect Dis 2010;201:650-652. PMCID:PMC2849627.
Hendrickson S, Lautenberger J, Chinn L, Malasky M, Sezgin E, Kingsley LA, Goedert J, Kirk GD, Gomperts E, Buchbinder S, Troyer J, Obrien S. Plos ONE 2010;5:e12862. PMCID: PMC2943476.
Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, Maust BS, Wong KG, Troyer JL, Goedert JJ, Kessing BD, Detels R, Wolinsky SM, Martinson J, Buchbinder S, Kirk GD, Jacobson LP, Margolick JB, Kaslow RA, O'Brien SJ, Mullins JI. J Infect Dis 2010;201:618-26. PMCID: PMC2928718.
Huang CY, Qin J, Wang MC. Biometrics 2010;66:39-49. PMCID:PMC2875299.
Kucirka LM, Farzadegan H, Feld JJ, Mehta SH, Winters M, Glenn JS, Kirk GD, Segev DL, Nelson KE, Marks M, Heller T, Golub ET. J Infect Dis 2010;202:845-852. PMCID: PMC2924454.
Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, Hoots WK, Buchbinder S, Carrington M, Thio CL. J Infect Dis 2010;202:1749-53. PMCID: PMC2974014.
Mehta SH, Kirk GD, Astemborski J, Galai N, Celentano D. Clin Infect Dis 2010;50:1664-1671. PMCID: PMC2874101.
Mehta SH, Vogt SL, Srikrishnan AK, Vasudevan CK, Murugavel KG, Saravanan S, Anand S, Kumar MS, Ray SC, Celentano DD, Solomon S, Solomon SS. . Indian J Med Res 2010;132:706-14. PMCID: PMC3102459.
Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL. J Infect Dis 2010;201:1371-80. PMCID: PMC2853721.
Nandi A, Glass TA, Cole SR, Chu H, Galea S, Celentano DD, Kirk GD, Vlahov D, Latimer WW, Mehta SH. Am J Epidemiol 2010; 171: 391-398. PMCID: PMC2877451.
Sander PM, Cole SR, Ostrow DG, Mehta SH, Kirk GD. Drug Alcohol Depend 2010;111: 173-176. PMCID: PMC2930039.
Shiels MS, Cole SR, Mehta SH, Kirk GD. J Acquir Immune Defic Syndr 2010;55:510-515. PMCID: PMC2974802.
Solomon SS, Celentano DD, Srikrishnan AK, Vasudevan CK, Murugavel KG, Iqbal S, Anand S, Kumar MS, Latkin C, Solomon S, Mehta SH. Am J Epidemiol 2010;172:1259-1267. PMCID: PMC3025630.
Yanik E, Lucas GM, Kirk GD, Mehta SH. Clin J Am Soc Nephrology 2010;5:1836-1843. PMCID: PMC2974385.
2009
An P, Johnson R, Phair J, Kirk GD, Yu XF, Donfield S, Buchbinder S, Goedert JJ, Winkler CA. J Infect Dis 2009;200: 1054-8.
Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD. Clin Infect Dis 2009; 49:1582-90. PMCID: PMC2871149.
Kavasery R, Galai N, Astemborski J, Lucas GM, Celentano D, Kirk GD, Mehta SH. JAIDS 2009;50:360-6. PMCID: PMC2782439.
Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, Higgins Y, Moore R, Afdhal N, Torbenson M, Sulkowski M, Thomas DL. Clin Infect Dis 2009;48:963-72. PMCID: PMC2715996.
Lau B, Gange SK, Kirk GD, Moore RD. Epidemiology 2009;20:664-72. PMCID: PMC2818534.
Marshall MM, McCormack MC, Kirk GD. AIDS Educ Prev 2009;21(3 Suppl): 28-39. PMCID: PMC2774230.
Mehta SH, Lau B, Afdhal NH, Thomas DL. J Hepatol 2009;50:36-41. PMCID: PMC2637134.
Phelan D, Gange S, Ahdieh-Grant L, Mehta SH, Kirk GD, Shah K, Gravitt P. Sex Transm Dis 2009;36:149-56. PMCID: PMC2888629.
Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A,Marco V, Pirisi M, Voiculescu M, Guido M, Bourliere M,Noventa F, Alberti A. Hepatology 2009; 49:1821-1927.
Sezgin E, Lind JM, Shrestha S, Hendrickson S, Goedert JJ, Buchbinder S, Donfield SM, Kirk GD, Phair J, O'Brien SL, Smith MW. Hum Genet 2009;125:281-94. PMCID:PMC2885350.
Shiels MS, Cole SR, Kirk GD, Poole C. JAIDS 2009 52:611-22. PMCID: PMC2790038.
The North American AIDS Cohort Collaboration on Research and Design. N Engl J Med 2009; 360: 1815-26. PMCID: PMC2854555.
Thomas R, Apps R, Qi Y, O’Connor G, Ge D, Fellay J, Martin JN, Margolick J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Deeks SG, Walker BD, Goldstein D, McVicar DW, Moffett A, Carrington M. Nat Genet 2009; 41:1290-1294. PMCID: PMC2887091.
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M. Nature 2009;461:798-801.
Winkler CA, An P, Johnson R, Nelson GW, Kirk GD. Cell Host Microbe 2009;5:411-3.
2008
An P, Thio CL, Kirk GD, Donfield S, Goedert JJ, Winkler CA. J Infect Dis 2008;198:1159-65. PMCID: PMC2674361.
Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Kirk GD, Mehta SH, Cox A, Thomas DL, Ray SC. Gastroenterology 2008;135:226-33. PMCID: PMC2644903.
Blankson JN, Klinzman D, Astemborski J, Thomas DL, Kirk GD, Stapleton J. AIDS 2008;22:2398-400 (letter).
Celentano DD, Latimore AD, Mehta SH. Curr HIV/AIDS Rep 2008;5:212-8. PMCID: PMC2801160.
Golub JE, Astemborski J, Ahmed MA, Cronin WA, Mehta SH, Kirk GD, Vlahov D, Chaisson RE. JAIDS 2008;49:532-7. PMCID: PMC2637943.
Hendrickson SL, Hutcheson HB, Ruiz-Pesini E, Poole JC, Lautenberger J, Sezgin E, Kingsley L, Goedert JJ, Vlahov D, Donfield S, Wallace DC, O'Brien SJ. AIDS 2008 30;22:2429-39. PMCID: PMC2699618.
Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA. Nat Genetics 2008;40:1175-84. PMCID: PMC2827354.
Mehta SH, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee S, Thomas DL. J Community Health 2008;33:126-33.
Pandey JP, Luo Y, Elston RC, Wu Y, Philp FH, Astemborski J, Thomas DL, Netski DM. Hum Immunol 2008;69:58-64. PMCID: PMC2364665.
Shardell M, Scharfstein DO, Vlahov D, Galai N. Stat Med 2008;27:5861-79. PMCID: PMC2796438.
Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SL, Smith MW. Intl J Immunogenetics 2008;35:255-64. PMCID: PMC2874896.
2007
An P, Duggal P, Wang LH, O'Brien SJ, Donfield S, Goedert JJ, Phair J, Buchbinder S, Kirk GD, Winkler CA. PLoS Genet 2007;3:e19.
Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Clin Infect Dis 2007;45:1625-32.
Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Klein MB, Martin JN, McKaig RG, Rodriguez B, Rourke SB, Sterling TR, Freeman AM, Moore RD. Int J Epidemiol 2007;36:294-301.
Huang Y, Yang H, Borg BB, Su X, Rhodes SL, Yang K, Tong X, Tang G, Howell CD, Rosen HR, Thio CL, Thomas DL, Alter HJ, Sapp RK, Liang TJ. Proc Natl Acad Sci USA 2007;104:985-90.
Kannangai R, Vivekanandan P, Netski D, Mehta S, Kirk GD, Thomas DL, Torbenson M. J Clin Virol 2007;39:101-105.
Kirk GD, Merlo C, O'Driscoll P, Mehta SH, Galai N, Vlahov D, Samet J, Engels EA. Clin Infect Dis 2007;45:103-110.
Kirk GD, Vlahov D. Clin Infect Dis 2007;45:377-380.
Lucas GM, Mehta SH, O’Driscoll P, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. AIDS 2007;21: 2435-43.
Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. Nat Genet 2007;39:733-740.
McKenzie LM, Henrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki MH, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA. J Am Soc Nephrol 2007;18:2987-95.
Mehta SH, Lucas GM, Astemborski J, Kirk GD, Vlahov D, Galai N. AIDS Care 2007;19:637-645.
Morris JD, Golub ET, Mehta SH, Jacobson LP, Gange SJ. AIDS Res Ther 2007;4:12.
Netski DM, Mosbruger T, Astemborski J, Mehta SH, Thomas DL, Cox AL. J Infect Dis 2007;195:857-863.
Semba RD, Ricketts EP, Mehta S, Netski D, Thomas D, Kirk G, Wu AW, Vlahov D. J Acquir Immune Defic Syndr 2007;45:298-303.
Semba RD, Ricketts EP, Mehta SF, Kirk GD, Latkin C, Galai N, Vlahov D. Am J Drug Alcohol Abuse 2007;33:71-80.
Vlahov D, O'Driscoll P, Mehta SH, Ompad DC, Gern R, Galai N, Kirk GD. Addiction 2007;102 Suppl 1:771-7.
Wang XH, Netski DM, Astemborski J, Mehta SH, Torbenson MS, Thomas DL, Ray SC. J Virol 2007;81:6513-6522.
2006
Bashirova AA, Bleiber G, Qi Y, Hutcheson H, Yamashita T, Johnson RC, Cheng J, Alter G, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, May M, Maldarelli F, Jacobson L, O'Brien S J, Telenti A, Carrington M. J Virol 2006;80:6757-63.
Deloria-Knoll M, Steinhoff M, Semba RD, Nelson K, Vlahov D, Meinert CL. Vaccine 2006;24:1670-9.
Javanbakht H, An P, Gold B, Petersen DC, O'Huigin C, Nelson GW, O'Brien SJ, Kirk GD, Detels R, Buchbinder S, Donfield S, Shulenin S, Song B, Perron MJ, Stremlau M, Sodroski J, Dean M, Winkler C. Virology 2006;354:15-27.
Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. AIDS Res Hum Retroviruses 2006;22:14-21.
Mehta SH, Galai N, Astemborski J, Celentano DD, Strathdee SA, Vlahov D, Nelson KE. J Acquir Immune Defic Syndr 2006;43:368-72.
Modi WS, Lautenberger J, An P, Scott K, Goedert JJ, Kirk GD, Buchbinder S, Phair J, Donfield S, O'Brien SJ, Winkler C. Am J Hum Genet 2006;79:120-8.
Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee SA. Am J Prev Med 2006;31:261-4.
Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Drug Alcohol Depend 2006;83:104-110.
Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, Kirk GD, O'Brien SJ, Trowsdale J, Carrington M. PLoS Pathog 2006;2:e79.
Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Drug Alcohol Depend 2006;83:147-56.
Shrestha S, Smith MW, Broman KW, Farzadegan H, Vlahov D, Strathdee SA. J Acquir Immune Defic Syndr 2006;43:335-43.
Shrestha S, Strathdee SA, Broman KW, Smith MW. Electrophoresis 2006;27:409-15.
Shrestha S, Strathdee SA, Galai N, Oleksyk T, Fallin MD, Mehta S, Schaid D, Vlahov D, O'Brien SJ, Smith MW. J Infect Dis 2006;193:16-26.
Smit E, Crespo CJ, Semba RD, Jaworowicz D, Vlahov D, Ricketts EP, Ramirez-Marrero FA, Tang AM. AIDS Care 2006;18:1040-5.
Vlahov D, Celentano DD. Cad Saude Publica 2006;22:705-718.
Washington TA, Galai N, Cohn S, Celentano DD, Vlahov D, Strathdee SA. Arch Sex Behav 2006;35:67-74.
Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL. Hepatology 2006;43:788-95.
Wisniewski AB, Brown TT, John M, J. C,Jr, Golub ET, Ricketts EP, Wand G, Dobs AS. Psychoneuroendocrinology 2006;31:250-5.
2005
Chiang CT, James LF, Wang MC. Lifetime Data Anal 2005;11:489-509.
Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, V S, Ray SC, Thomas DL. Clin Infect Dis 2005;40:951-8.
Dancheck B, Tang AM, Thomas AM, Smit E, Vlahov D, Semba RD. J Acquir Immune Defic Syndr 2005;40:198-201.
Duggal P, Winkler CA, An P, Yu XF, Farzadegan H, O'Brien SJ, Beaty TH, Vlahov D. . J Acquir Immune Defic Syndr 2005;38:584-9.
Galai N, Vlahov D, Bareta JC, Wang C, Cohn S, Sterling TR. . J Acquir Immune Defic Syndr 2005;38:74-81.
Golub ET, Bareta JC, Mehta SH, McCall LD, Vlahov D, Strathdee SA. . Subst Use Misuse 2005;40:1751-64.
Golub ET, Purvis LA, Sapun M, Safaeian M, Beyrer C, Vlahov D, Strathdee SA. AIDS Behav 2005;9:301-9.
Lai S, Lima JA, Lai H, Vlahov D, Celentano D, Tong W, Bartlett JG, Margolick J, Fishman EK. . Arch Intern Med 2005;165:690-5.
Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. . AIDS 2005;19 Suppl 3:S179-89.
Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O'Brien S J, Winkler C. Genes Immun 2005;6:691-8.
Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW. Genes Immun 2005;6:347-57.
Orloff MS, Iyengar SK, Winkler CA, Goddard KA, Dart RA, Ahuja TS, Mokrzycki M, Briggs WA, Korbet SM, Kimmel PL, Simon EE, Trachtman H, Vlahov D, Michel DM, Berns JS, Smith MC, Schelling JR, Sedor JR, Kopp JB. V Physiol Genomics 2005;21:212-21.
Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee SA. AIDS Behav 2005;9:289-99.
Smit E, Semba RD, Pilibosian E, Vlahov D, Tun W, Purvis L, Tang AM. AIDS Patient Care STDS 2005;19:19-30.
Thio CL, Mosbruger T, Astemborski J, Greer S, Kirk GD, O'Brien SJ, Thomas DL. J Virol 2005;79:9192-6.
Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TR. Am J Epidemiol 2005;161:999-1012.
Wang C, Vlahov D, Galai N, Cole SR, Bareta J, Pollini R, Mehta SH, Nelson KE, Galea S. . AIDS 2005;19:935-42.
2004
An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S, Goedert JJ, Phair J, Buchbinder S, O'Brien SJ, Telenti A, Winkler CA. J Virol 2004;78:11070-6.
Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein RS. J Clin Virol 2004;31:210-4.
Frangakis CE, Brookmeyer RS, Varadhan R, Safaeian M, Vlahov D, Strathdee SA. Methodology for evaluating a partially controlled longitudinal treatment using principal stratification, with application to a needle exchange program. J Am Stat Assoc 2004;99:239-49.
Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee S, Hilgartner MW, O'Brien SJ, Carrington M. Genes Immun 2004;5:261-6.
Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004;305:872-4.
Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, van Kooyk Y, Detels R, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. J Virol 2004;78:14053-6.
Poundstone KE, Strathdee SA, Celentano DD. Epidemiol Rev 2004; 26:22-35.
Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr 2004;35:503-10.
Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O'Brien SJ, Reich D. A high-density admixture map for disease gene discovery in African Americans. Am J Hum Genet 2004;74:1001-13.
Templeton AR, Reichert RA, Weisstein AE, Yu XF, Markham RB. Genetics 2004;167:1547-61.
Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O'Brien SJ, Astemborski J, Thomas DL. Genes Immun 2004;5:294-300.
Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D, O'Brien SJ, Astemborski J, Thomas DL. J Virol 2004;78:11258-62.
Tong W, Lima JA, Lai H, Celentano DD, Dai S, Lai S. Relation of coronary artery calcium to left ventricular mass in African-Americans. Am J Cardiol 2004;93:490-2.
Tong W, Lima JA, Meng Q, Flynn E, Lai S. Long-term cocaine use is related to cardiac diastolic dysfunction in an African-American population in Baltimore, Maryland. Int J Cardiol 2004;97:25-8.
Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. Hepatology 2004;39:51-7.
Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Clin Infect Dis 2004;38:1167-74.
Vlahov D, Wang CL, Galai N, Bareta J, Mehta SH, Strathdee SA, Nelson KE. Addiction 2004;99:946-54.
Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. J Infect Dis 2004;190:1046-54.
Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, O'Brien S J, Phair J, Vlahov D, Jacobson LP, Rappaport J, Vasilescu A, Bertin-Maghit S, An P, Lu W, Andrieu JM, Schachter F, Therwath A, Zagury JF. Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression. J Acquir Immune Defic Syndr 2004;37:1534-8.
2003
An P, Vlahov D, Margolick JB, Phair J, O'Brien TR, Lautenberger J, O'Brien SJ, Winkler CA. J Infect Dis 2003;188:228-31.
Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, Winkler CA. Genes Immun 2003;4:245-50.
Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD. Am J Epidemiol 2003;158:695-704.
Golub ET, Astemborski JA, Hoover DR, Anthony JC, Vlahov D, Strathdee SA. Psychological distress and progression to AIDS in a cohort of injection drug users. J Acquir Immune Defic Syndr 2003;32:429-34.
Henderson LA, Vlahov D, Celentano DD, Strathdee SA. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J Acquir Immune Defic Syndr 2003;32:229-37.
Juday TR, Wu A, Celentano DD, Frick KD, Wang MC, Vlahov D. Subst Abus 2003;24:27-41.
Lai S, Lai H, Celentano DD, Vlahov D, Ren S, Margolick J, Lima JA, Bartlett JG. AIDS Patient Care STDS 2003;17:211-9.
Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Margolick JB, Lai S. Int J Cardiol 2003;88:191-8.
Modi WS, O'Brien TR, Vlahov D, Buchbinder S, Gomperts E, Phair J, O'Brien SJ, Winkler C. Immunogenetics 2003;55:157-64.
Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS 2003;17:377-87.
Royal W, Vlahov D, Lyles C, Gajewski CD. Clin Infect Dis 2003;37 Suppl 5:S427-32.
Tun W, Celentano DD, Vlahov D, Strathdee SA. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS 2003;17:1953-62.
Zwahlen M, Vlahov D. Int J Epidemiol 2003;32:715-6.
2002
An P, Nelson GW, Wang L, Donfield S, Goedert JJ, Phair J, Vlahov D, Buchbinder S, Farrar WL, Modi W, O'Brien SJ, Winkler CA. Proc Natl Acad Sci U S A 2002;99:10002-7.
Celentano DD, Cohn S, Davis RO, Vlahov D. J Urban Health 2002;79:245-56.
Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. Drug Alcohol Depend 2002;66:189-98.
Lai S, Lai H, Meng Q, Tong W, Vlahov D, Celentano D, Strathdee S, Nelson K, Fishman EK, Lima JA. Am J Cardiol 2002;90:326-8.
Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev 2002;14:367-78.
Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M. Nat Genet 2002;31:429-34.
Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. Lancet 2002;359:1478-83.
Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee S, Nelson KE, Tong W, Lai S. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 2002;30:306-10.
Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee SA, Nelson KE, Wu KC, Chen S, Tong W, Lai S. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J 2002;144:642-8.
Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Am J Epidemiol 2002;156:641-53.
Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. . Hepatology 2002;35:1247-55.
Riley ED, Safaeian M, Strathdee SA, Brooner RK, Beilenson P, Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Subst Use Misuse 2002;37:1869-86.
Riley ED, Wu AW, Junge B, Marx M, Strathdee SA, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse 2002;28:497-511.
Safaeian M, Brookmeyer R, Vlahov D, Latkin C, Marx M, Strathdee SA. Am J Epidemiol 2002;155:169-75.
Semba RD, Shah N, Strathdee SA, Vlahov D. High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection. J Acquir Immune Defic Syndr 2002;29:142-4.
Semba RD, Shah N, Vlahov D. Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users. Int J STD AIDS 2002;13:119-23.
Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J. J Infect Dis 2002;186:1181-5.
Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL. J Virol 2002;76:4792-7.
Wang MC, Chiang CT. Stat Med 2002;21:445-56.
Wilson LE, Thomas DL, Astemborski J, Freedman TL, Vlahov D. J Infect Dis 2002;185:1761-6.
2001
Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, Gallant JE. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001;15:1707-15.
Celentano DD, Munoz A, Cohn S, Vlahov D. Drug Alcohol Depend 2001;61:315-22.
Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001;344:1668-75.
Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001;135:782-95.
Knowlton AR, Hoover DR, Chung SE, Celentano DD, Vlahov D, Latkin CA. Drug Alcohol Depend 2001;64:55-62.
Knowlton AR, Latkin CA, Schroeder JR, Hoover DR, Ensminger M, Celetano DD. AIDS Care 2001;13:549-59.
Latkin C, Knowlton A, V F, Hoover D, Hachey M, Celentano D. Injection drug users' disclosure of HIV seropositive status to network members. AIDS Behav 2001;5:297-305.
Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol 2001;75:3259-67.
Pilowsky DJ, Lyles CM, Cross SI, Celentano D, Nelson KE, Vlahov D. Drug Alcohol Depend 2001;61:113-22.
Riley ED, Chaisson RE, Robnett TJ, Vertefeuille J, Strathdee SA, Vlahov D. Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors. Am J Respir Crit Care Med 2001;164:82-5.
Sadaphal P, Astemborski J, Graham NM, Sheely L, Bonds M, Madison A, Vlahov D, Thomas DL, Sterling TR. Clin Infect Dis 2001;33:1687-91.
Schroeder JR, Latkin CA, Hoover DR, Curry AD, Knowlton AR, Celentano DD. Ann Epidemiol 2001;11:389-94.
Semba RD, Shah N, Vlahov D. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26:315-9.
Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001;344:720-5.
Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 2001;161:1281-8.
Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. [The difference between men and women drug users in seroconversion risk factors]. Sidahora 2001;25-6.
Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Marti D, Astemborski J, Carrington M. J Infect Dis 2001;184:16-21.
Valente TW, Foreman RK, Junge B, Vlahov D. J Urban Health 2001;78:340-9.
Vlahov D, Des Jarlais DC, Goosby E, Hollinger PC, Lurie PG, Shriver MD, Strathdee SA. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol 2001;154:S70-7.
Vlahov D, Safaien M, Lai S, Strathdee SA, Johnson L, Sterling T, Celentano DD. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS 2001;15:2311-6.
Wilson LE, Umemura T, Astemborski J, Ray SC, Alter HJ, Strathdee SA, Vlahov D, Thomas DL. J Infect Dis 2001;184:1315-9.
2000
Ahdieh L, Munoz A, Vlahov D, Trimble CL, Timpson LA, Shah K. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 2000;151:1148-57.
An P, Martin MP, Nelson GW, Carrington M, Smith MW, Gong K, Vlahov D, O'Brien SJ, Winkler CA. Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS 2000;14:2117-22.
Knowlton A, Latkin C, Chung SE, Hoover D, Ensminger M, Celentano D. HIV and depressive symptoms among low-income illicit drug users. AIDS Behav 2000;4:353-360.
Marx MA, Crape B, Brookmeyer RS, Junge B, Latkin C, Vlahov D, Strathdee SA. Trends in crime and the introduction of a needle exchange program. Am J Public Health 2000;90:1933-6.
Safaeian M, Wilson LE, Taylor E, Thomas DL, Vlahov D. HTLV-II and bacterial infections among injection drug users. J Acquir Immune Defic Syndr 2000;24:483-7.
Shah NG, Celentano DD, Vlahov D, V S, Johnson L, Nelson KE, Strathdee SA. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000;14:2035-43.
Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, O'Brien TR, Vlahov D, Buchbinder S, Giorgi J, Rinaldo C, Donfield S, Willoughby A, O'Brien SJ, Smith MW. Proc Natl Acad Sci U S A 2000;97:14467-72.
Shrestha S, Strathdee SA, Brahmbhatt H, Farzadegan H, Vlahov D, Smith MW. Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes. AIDS 2000;14:1507-13.
Song JY, Safaeian M, Strathdee SA, Vlahov D, Celentano DD. J Urban Health 2000;77:678-87.
Tang AM, Smit E, Semba RD, Shah N, Lyles CM, Li D, Vlahov D. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. J Acquir Immune Defic Syndr 2000;23:321-6.
Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol 2000;38:575-7.
Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. JAMA 2000;284:450-6.
Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA. J Infect Dis 2000;181:844-51.
Thomas DL, Strathdee SA, Vlahov D. Long-term prognosis of hepatitis C virus infection. JAMA 2000;284:2592.
Vlahov D. The role of epidemiology in needle exchange programs. Am J Public Health 2000;90:1390-2.
Wahlstrom JT, Tang A, Cofrancesco J, N. S,Jr, Dobs AS. Drug Alcohol Depend 2000;60:311-3.
1999
Carneiro M, Fuller C, Doherty MC, Vlahov D. Drug Alcohol Depend 1999;54:83-6.
Carneiro M, Yu XF, Lyles C, Templeton A, Weisstein AE, Safaeian M, Farzadegan H, Vlahov D, Markham RB. J Infect Dis 1999;180:1025-32.
Carrieri MP, Moatti JP, Vlahov D, Obadia Y, Reynaud-Maurupt C, Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J Epidemiol Community Health 1999;53:4-8.
Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-52.
Comer JA, Tzianabos T, Flynn C, Vlahov D, Childs JE. Serologic evidence of rickettsialpox (Rickettsia akari) infection among intravenous drug users in inner-city Baltimore, Maryland. Am J Trop Med Hyg 1999;60:894-8.
Dean M, Jacobson LP, McFarlane G, Margolick JB, Jenkins FJ, Howard OM, Dong HF, Goedert JJ, Buchbinder S, Gomperts E, Vlahov D, Oppenheim JJ, O'Brien SJ, Carrington M. Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res 1999;59:3561-4.
Inglesby TV, Rai R, Astemborski J, Gruskin L, Nelson KE, Vlahov D, Thomas DL. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology 1999;29:590-6.
Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NM, Chaisson RE, Bishai WR. J Infect Dis 1999;179:1297-300.
Krol A, Flynn C, Vlahov D, Miedema F, Coutinho RA, van Ameijden EJ. Drug Alcohol Depend 1999;54:145-54.
Lyles CM, Graham NM, Astemborski J, Vlahov D, Margolick JB, Saah AJ, Farzadegan H. Eur J Epidemiol 1999;15:99-108.
Pezzotti P, Galai N, Vlahov D, Rezza G, Lyles CM, Astemborski J. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:275-82.
Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, Quinn TC. J Infect Dis 1999;180:666-72.
Strathdee SA, Celentano DD, Shah N, Lyles C, V S, Macalino G, Nelson K, Vlahov D. J Urban Health 1999;76:448-60.
Sulkowski M, Thomas DL. Viral hepatitis among injection drug users. Viral Hepatitis Reviews 1999;4:229-244.
Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski J, Thomas DL. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis 1999;179:1004-6.
van Ameijden EJ, Krol A, Vlahov D, Flynn C, van Haastrecht HJ, Coutinho RA. Subst Use Misuse 1999;34:845-65.
Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999;29:908-14.
1998
Bishai WR, Graham NM, Harrington S, Pope DS, Hooper N, Astemborski J, Sheely L, Vlahov D, Glass GE, Chaisson RE. JAMA 1998;280:1679-84.
Celentano DD, Vlahov D, Cohn S, V S, Obasanjo O, Moore RD. JAMA 1998;280:544-6.
Donahoe RM Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 1998;83:77-87.
Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D. Lancet 1998;352:1510-4.
Gleghorn AA, Gee G, Vlahov D. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18 Suppl 1:S89-93.
Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe use and reuse: effects of syringe exchange programs in four cities. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18 Suppl 1:S37-44.
Keyl PM, Gruskin L, Casano K, Montag H, Junge B, Vlahov D. Community support for needle exchange programs and pharmacy sale of syringes: a household survey in Baltimore, Maryland. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18 Suppl 1:S82-8.
Latkin C, Glass GE, Duncan T. Drug Alcohol Depend 1998;50:167-75.
Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Rep 1998;113 Suppl 1:151-9.
Latkin CA, Mandell W, Knowlton AR, Doherty MC, Vlahov D, Suh T, Celentano DD. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev 1998;10:257-63.
Latkin CA, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998;93:1191-7.
Lyles CM, Vlahov D, Farzadegan H, Astemborski J, Margolick JB, Masters BA, Schroeder J, Quinn TC. Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups. J Clin Microbiol 1998;36:3647-52.
Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF. Proc Natl Acad Sci U S A 1998;95:12568-73.
Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998;282:1907-11.
Riley E, Beilenson P, Vlahov D, Smith L, Koenig M, Jones TS, Doherty M. Operation Red Box: a pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18 Suppl 1:S120-5.
Sterling TR, Moore RD, Graham NM, Astemborski J, Vlahov D, Chaisson RE. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. AIDS 1998;12:1451-7.
Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, Nelson KE. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998;177:539-42.
Valente TW, Foreman RK, Junge B, Vlahov D. Satellite exchange in the Baltimore Needle Exchange Program. Public Health Rep 1998;113 Suppl 1:90-6.
Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H. JAMA 1998;279:35-40.
Vlahov D, Junge B. The role of needle exchange programs in HIV prevention. Public Health Rep 1998;113 Suppl 1:75-80.
Wang Z, Lyles CM, Beyrer C, Celentano DD, Vlahov D, Natpratan C, Markham R, Khamboonruang C, Nelson K, Yu XF. Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand. J Infect Dis 1998;178:1507-11.
Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O'Brien SJ. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-93.
Yu XF, Wang Z, Vlahov D, Markham RB, Farzadegan H, Margolick JB. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. J Infect Dis 1998;178:388-96.
Zhang H, Flynn C, Nelson KE, Chen W, Kawalski R, Vlahov D. HIV/HTLV-II coinfection and CD4+ cell count controlling for plasma HIV viral load in injection drug users in Baltimore. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:397-8.
1997
Converse PJ, Jones SL, Astemborski J, Vlahov D, Graham NM. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis 1997;176:144-50.
Doherty MC, Garfein RS, Vlahov D, Junge B, Rathouz PJ, Galai N, Anthony JC, Beilenson P. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol 1997;145:730-7.
Erbelding EJ, Vlahov D, Nelson KE, Rompalo AM, Cohn S, Sanchez P, Quinn TC, Brathwaite W, Thomas DL. Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis 1997;176:1397-400.
Saah AJ, Spruill C, Hoover DR, Prevots R, Taylor E, Margolick JB, Vlahov D. Helper T-lymphocyte count. TRAx CD4 test kit versus conventional flow cytometry. Arch Pathol Lab Med 1997;121:960-2.
Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, Lyles CM, Vlahov D. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis 1997;176:586-92.
Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, Purcell RH. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997;35:1244-7.
Villano SA, Nelson KE, Vlahov D, Purcell RH, Saah AJ, Thomas DL. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis 1997;25:726-8.
Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997;35:3274-7.
Vlahov D, Junge B, Brookmeyer R, Cohn S, Riley E, Armenian H, Beilenson P. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:400-6.
1996
Ahmed F, Steinhoff MC, Rodriguez-Barradas MC, Hamilton RG, Musher DM, Nelson KE. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis 1996;173:83-90.
Crum RM, Galai N, Cohn S, Celentano DD, Vlahov D. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis. Alcohol Clin Exp Res 1996;20:364-71.
Galai N, Margolick JB, Astemborski J, Vlahov D. Clin Immunol Immunopathol 1996;79:134-41.
Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
Graham NM, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med 1996;156:889-94.
Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:273-80.
Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol 1996;24:341-64.
Manoff SB, Farzadegan H, Munoz A, Astemborski JA, Vlahov D, Rizzo RT, Solomon L, Graham NM. The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. J Infect Dis 1996;174:299-308.
Manoff SB, Vlahov D, Herskowitz A, Solomon L, Munoz A, Cohn S, Willoughby SB, Nelson KE. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology 1996;7:566-70.
Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996;12:496-501.
Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996;174:690-5.
1995
Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med 1995;155:2111-7.
Concha M, Selnes OA, McArthur JC, Nance-Sproson T, Updike ML, Royal W,3rd, Solomon L, Vlahov D. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int J Addict 1995;30:823-41.
Galai N, Vlahov D, Margolick JB, Chen K, Graham NM, Munoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:66-74.
Gershon RR, Vlahov D, Farzadegan H, Alter MJ. Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infect Control Hosp Epidemiol 1995;16:194-7.
Gleghorn AA, Jones TS, Doherty MC, Celentano DD, Vlahov D. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:97-103.
Harrison K, Vlahov D, Jones K, Charron K, Clements ML. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:386-90.
Holmberg SD, Conley LJ, Luby SP, Cohn S, Wong LC, Vlahov D. Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:291-6.
Kunzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM. J Infect Dis 1995;171:822-8.
Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, Knowlton A. Drug Alcohol Depend 1995;38:1-9.
Latkin C, Mandell W, Vlahov D, Knowlton A, Oziemkowska M, Celentano D. Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance. Social Networks 1995;17:219-228.
Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. Self-reported reasons for needle sharing and not carrying bleach among injection drug users in Baltimore, MD. J Drug Issues 1995;25:865-870.
Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol 1995;142:331-41.
Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. J Infect Dis 1995;171:797-804.
Nelson KE, Vlahov D, Solomon L, Cohn S, Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med 1995;155:1305-11.
Roca J, Vlahov D, Borrell C, Jansa JM, Brugal T, Yazbeck H, Munoz A. Geographic variation in HIV infection among injecting drug users within Barcelona. Int J Addict 1995;30:219-29.
Semba RD, Caiaffa WT, Graham NM, Cohn S, Vlahov D. J Infect Dis 1995;171:1196-202.
Solomon L, Vlahov D, Astemborski J, Galai N. Factors associated with initiation of zidovudine in a cohort of injection drug users. J Drug Issues 1995;25:225.
Sorkin JD, Bolton PA, Greenblatt J, Sithisarankul P, Vlahov D, Graham NM. Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. Epidemiology 1995;6:172-7.
Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995;74:212-20.
Vlahov D. Deregulation of the sale and possession of syringes for HIV prevention among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:71-2.
Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan JE. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:89-96.
1994
Alcabes P, Munoz A, Vlahov D, Friedland G. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol 1994;4:17-26.
Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994;84:382-7.
Aylward RB, Vlahov D, Munoz A, Rapiti E. Validation of the proposed World Health Organization staging system for disease and infection in a cohort of intravenous drug users. AIDS 1994;8:1129-33.
Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol 1994;139:918-26.
Caiaffa WT, Vlahov D, Graham NM, Astemborski J, Solomon L, Nelson KE, Munoz A. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med 1994;150:1493-8.
Celentano DD, Munoz A, Cohn S, Nelson KE, Vlahov D. Drug-related behavior change for HIV transmission among American injection drug users. Addiction 1994;89:1309-17.
Chilcoat HD, Munoz A, Vlahov D, Anthony JC. Low power? Use two-dimensional confidence regions as a graphical method for depicting uncertainty. Drug Alcohol Depend 1994;36:39-48.
Gershon RR, Curbow B, Kelen G, Celantano D, Lears K, Vlahov D. Am J Infect Control 1994;22:293-9.
Gleghorn AA, Doherty MC, Vlahov D, Celentano DD, Jones TS. Inadequate bleach contact times during syringe cleaning among injection drug users. J Acquir Immune Defic Syndr 1994;7:767-72.
Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 1994;24:1025-32.
Kendig N, Stough T, Austin P, Kummer L, Swetz A, Vlahov D. Profile of HIV seropositive inmates diagnosed in Maryland's state correctional system. Public Health Rep 1994;109:756-60.
Khabbaz RF, Ksiazek TG, Caiaffa WT, Rollin PE, Taylor E, Vlahov D. Seoul hantavirus seropositivity among injecting drug users in Baltimore. J Infect Dis 1994;170:1636-7.
Latkin C, Mandell W, Oziemkowska M, Vlahov D, Celentano D. The relationships between sexual behavior, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland. Sex Transm Dis 1994;21:161-7.
Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol 1994;22:415-30.
Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev 1994;16:418-36.
Mandell W, Vlahov D, Latkin C, Carran D, Oziemkowska M, Reedt L. Changes in HIV risk behaviors among counseled injecting drug users. J Drug Issues 1994;24:555-567.
Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. Correlates of needle sharing among injection drug users. Am J Public Health 1994;84:920-3.
Margolick JB, Munoz A, Vlahov D, Astemborski J, Solomon L, He XY, Nelson KE, Saah AJ. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Arch Intern Med 1994;154:869-75.
McMillian T, Dorsey E, Beilenson P, Vlahov D. A community-based needle clean-up project. Am J Public Health 1994;84:1854.
Nelson KE, Vlahov D, Galai N, Astemborski J, Solomon L. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses 1994;10 Suppl 2:S201-5.
Schutz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend 1994;36:129-38.
Schutz CG, Vlahov D, Anthony JC, Graham NM. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J Clin Epidemiol 1994;47:191-5.
Vlahov D. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda. AIDS Res Hum Retroviruses 1994;10 Suppl 2:S3-6.
Vlahov D, Astemborski J, Solomon L, Galai N, Basarab L, Nelson KE. Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses 1994;10 Suppl 2:S265-8.
Vlahov D, Astemborski J, Solomon L, Nelson KE. Field effectiveness of needle disinfection among injecting drug users. J Acquir Immune Defic Syndr 1994;7:760-6.
Vlahov D, Brookmeyer RS. The evaluation of needle exchange programs. Am J Public Health 1994;84:1889-91.
Vlahov D, Ryan C, Solomon L, Cohn S, Holt MR, Akhter MN. A pilot syringe exchange program in Washington, DC. Am J Public Health 1994;84:303-4.
Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D, Ippolito G, V L, Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS 1994;8:345-50.
1993
Alcabes P, Munoz A, Vlahov D, Friedland GH. Incubation period of human immunodeficiency virus. Epidemiol Rev 1993;15:303-18.
Caiaffa WT, Graham NM, Vlahov D. Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol 1993;138:909-22.
Farzadegan H, Vlahov D, Solomon L, Munoz A, Astemborski J, Taylor E, Burnley A, Nelson KE. J Infect Dis 1993;168:327-31.
Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Am J Cardiol 1993;71:955-8.
Jason J, Solomon L, Celentano DD, Vlahov D. Potential use of mass media to reach urban intravenous drug users with AIDS prevention messages. Int J Addict 1993;28:837-51.
Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993;88:517-26.
Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Arch Intern Med 1993;153:1806-12.
Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993;153:2149-54.
Solomon L, Astemborski J, Warren D, Munoz A, Cohn S, Vlahov D, Nelson KE. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. Am J Epidemiol 1993;137:892-8.
Strickler HD, Blanchard JF, Vlahov D, Taylor E, Munoz A, Nelson KE, Margolick JB. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. AIDS 1993;7:361-7.
Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993;9:566-9.
Willoughby SB, Vlahov D, Herskowitz A. Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. Am J Cardiol 1993;71:446-7.
1992
Alcabes P, Vlahov D, Anthony JC. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading? Br J Addict 1992;87:47-54.
Alcabes P, Vlahov D, Anthony JC. Characteristics of intravenous drug users by history of arrest and treatment for drug use. J Nerv Ment Dis 1992;180:48-54.
Behrendt C, Vlahov D, Clak J, Kendig N. HIV infection and AIDS among U.S. prison inmates. Journal of Crime and Justice 1992;15:173-186.
Chaisson RE, Taylor E, Margolick JB, Munoz A, Solomon L, Cohn S, Nelson KE, Vlahov D. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr 1992;5:456-60.
Concha M, Graham NM, Munoz A, Vlahov D, Royal W,3rd, Updike M, Nance-Sproson T, Selnes OA, McArthur JC. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. Am J Epidemiol 1992;136:1338-48.
Galai N, Graham N, Chaisson R, Nelson KE, Vlahov D, Lewis J. Multidrug-resistant tuberculosis. N Engl J Med 1992;327:1172-3.
Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA 1992;267:369-73.
Latkin CA, Vlahov D, Anthony JC, Cohn S, Mandell W, Nelson KE. Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Maryland. Int J Addict 1992;27:717-25.
Margolick JB, Munoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson KE. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 1992;267:1631-6.
Munoz A, Vlahov D, Solomon L, Margolick JB, Bareta JC, Cohn S, Astemborski J, Nelson KE. Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1992;5:694-700.
Samuels JF, Vlahov D, Anthony JC, Chaisson RE. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict 1992;87:417-28.
Selnes OA, McArthur JC, Royal W,3rd, Updike ML, Nance-Sproson T, Concha M, Gordon B, Solomon L, Vlahov D. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992;42:1924-30.
Smith AM, Vlahov D, Menon AS, Anthony JC. Terminology for drug injection practices among intravenous drug users in Baltimore. Int J Addict 1992;27:435-53.
Smith MD, Celentano DD, Solomon L, Astemborski J, Vlahov D. J Infect Dis 1992;166:685-6.
Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, Solomon L, Pickens R, Uhl GR. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992;49:723-7.
Vlahov D. HIV-1 infection in the correctional setting. NIDA Res Monogr 1992;118:51-61.
Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep 1992;107:595-8.
1991
Anthony JC, Vlahov D, Celentano D, Menon AS, Margolick J, Cohn S, Nelson G, Polk BF. Self-reported interview data for a study of HIV-1 infection among intravenous drug users: Description of methods and preliminary evidence on validity. J Drug Issues 1991;21:739-757.
Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 1991;134:1175-89.
Celentano D, Vlahov D, Menon AS, Polk BF. J Drug Issues 1991;21:635-649.
Celentano DD, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health 1991;81:1291-5.
Donahue JG, Nelson KE, Munoz A, Vlahov D, Rennie LL, Taylor EL, Saah AJ, Cohn S, Odaka NJ, Farzadegan H. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991;134:1206-11.
Nelson KE, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony JC. Human immunodeficiency virus infection in diabetic intravenous drug users. JAMA 1991;266:2259-61.
Nelson KE, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Antohony JC, Hook EW,3rd. J Infect Dis 1991;164:457-63.
Royal W, Updike M, Selnes OA, Proctor TV, Nance-Sproson L, Solomon L, Vlahov D, Cornblath DR, McArthur JC. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991;41:1905-10.
Samuels JF, Vlahov D, Anthony JC, Solomon L, Celentano DD. The practice of 'frontloading' among intravenous drug users: association with HIV-antibody. AIDS 1991;5:343.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Public Health 1991;81:1285-90.
Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NM, Schwartz DH, Lucas AH, Chaisson RE. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med 1991;325:1837-42.
Vlahov D, Anthony JC, Celentano D, Solomon L, Chowdhury N. Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am J Drug Alcohol Abuse 1991;17:39-48.
Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, Solomon L, Polk BF. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991;109:75-100.
Vlahov D, Munoz A, Celentano DD, Cohn S, Anthony JC, Chilcoat H, Nelson KE. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland. Epidemiology 1991;2:444-6.
1990
Gershon RR, Vlahov D, Nelson KE. The risk of transmission of HIV-1 through non-percutaneous, non-sexual modes--a review. AIDS 1990;4:645-50.
Nelson KE, Vlahov D, Margolick J, Bernal M, Taylor E. Blood and plasma donations among a cohort of intravenous drug users. JAMA 1990;263:2194-7.
Tomas JM, Vlahov D, Anthony JC. Drug Alcohol Depend 1990;25:79-89.
1989
Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990;132:847-56.
Jones C, Vlahov D. Why don't intravenous drug users use condoms? J Acquir Immune Defic Syndr 1989;2:416-7.
Novick DM, Trigg HL, Des Jarlais DC, Friedman SR, Vlahov D, Kreek MJ. Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J Med Virol 1989;29:181-5.
1988
Vlahov D, Polk BF. Intravenous drug use and human immunodeficiency virus (HIV) infection in prison. AIDS Public Policy Journal 1988;3:42-46.
Vlahov D, Polk BF. Perspectives on infection with HIV-1 among intravenous drug users. Psychopharmacol Bull 1988;24:325-9.